Insurers place more prior authorization requirements on PCSK9 inhibitors than other similar cholesterol treatments.
More than 60% of very elderly patients with stage 3 lung cancer did not receive treatment.
Consistent delivery of an electric field could drastically increase glioblastoma survival.
Tisagenlecleucel (Kymriah) under review to treat non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia.
An HIV protein may interact with brain cells to increase neurodegeneration.
Top news of the day from across the health care landscape.
CDC notes link between jump in acute HCV cases and admissions to substance use disorder treatment facilities for opioid injections.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.